CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy of Bismuth-based Quadruple Therapy as First-line Treatment for Clarithromycin-resistant Helicobacter pylori Infection
Seung In Seo, Woon Geon Shin
Korean J Helicobacter  Up Gastrointest Res. 2022;22(3):243-245.   Published online August 24, 2022
DOI: https://doi.org/10.7704/kjhugr.2022.0025

Excel Download

Efficacy of Bismuth-based Quadruple Therapy as First-line Treatment for Clarithromycin-resistant Helicobacter pylori Infection
The Korean Journal of Helicobacter and Upper Gastrointestinal Research. 2022;22(3):243-245   Crossref logo
Link1 Link2 Link3

Seven Days of Bismuth-Based Quadruple Therapy Is as Effective for the First-Line Treatment of Clarithromycin-Resistant Confirmed Helicobacter pylori Infection as 14 Days of Bismuth-Based Quadruple Therapy
Journal of Clinical Medicine. 2022;11(15):4440   Crossref logo
Link1

The Efficacy of Two-Week Quadruple First-Line Therapy with Bismuth, Lansoprazole, Amoxicillin, Clarithromycin onHelicobacter pyloriEradication: A Prospective Study
Helicobacter. 2013;18(6):454-458   Crossref logo
Link1 Link2

Bismuth-containing quadruple therapy versus concomitant quadruple therapy as first-line treatment forHelicobacter Pyloriinfection in an area of high resistance to clarithromycin: A prospective, cross-sectional, comparative, open trial
Helicobacter. 2018;24(1):e12546   Crossref logo
Link1 Link2

Efficacy of two-week quadruple bismuth treatment versus levofloxacin concomitant Helicobacter Pylori infection regimen as empirical first-line therapy Syrian patients. A randomized controlled trial.
. 2020;   Crossref logo
Link1 Link2

Bismuth Containing Quadruple Therapy versus Tailored Therapy as first-line treatments for Helicobacter pylori infection in a high clarithromycin resistance area
. 2019;   Crossref logo
Link1 Link2

Bismuth Containing Quadruple Therapy versus Tailored Therapy as first-line treatments for Helicobacter pylori infection in a high clarithromycin resistance area
. 2019;   Crossref logo
Link1 Link2

Bismuth Containing Quadruple Therapy versus Tailored Therapy as first-line treatments for Helicobacter pylori infection in a high clarithromycin resistance area
. 2019;   Crossref logo
Link1 Link2

Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains
Helicobacter. 2012;17(4):269-276   Crossref logo
Link1 Link2

A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment ofHelicobacter pyloriInfection: A Pilot Study
Helicobacter. 2015;20(5):390-396   Crossref logo
Link1 Link2